Chugai Pharmaceutical Co., Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Chugai Pharmaceutical Co., Ltd. generated cash of $409,925,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$139,331,000,000 last year. Net change in cash is therefore $236,505,000,000.
Cash Flow
| 2014 | 37.03B | -14.35B | -24.38B |
|---|---|---|---|
| 2015 | 62.91B | -45.26B | -28.46B |
| 2016 | 38.78B | -10.10B | -33.41B |
| 2017 | 107.62B | -36.71B | -29.56B |
| 2018 | 119.07B | -74.06B | -35.01B |
| 2019 | 206.64B | -81.74B | -66.87B |
| 2020 | 205.03B | -98.31B | -99.49B |
| 2021 | 279.62B | -118.92B | -107.40B |
| 2022 | 244.11B | -145.99B | -145.64B |
| 2023 | 409.92B | -37.29B | -139.33B |
CHGCY Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 222.16B | 267.75B | 212.33B | 203.94B | 146.86B | 139.07B | 95.36B | 101.70B | 114.03B | 115.07B |
Operating activities | ||||||||||
Net income | 325.47B | 575.87B | 470.36B | 340.22B | 249.5B | 151.85B | 124.77B | 102.79B | 110.15B | 99.05B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 31.43B | 30.86B | 30.47B | 26.40B | 16.57B | 16.33B | 16.36B | 15.56B | 14.88B |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 342M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 342M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 409.92B | 244.11B | 279.62B | 205.03B | 206.64B | 119.07B | 107.62B | 38.78B | 62.91B | 37.03B |
Investing activities | ||||||||||
Purchases Of Investments | -545.98B | -519.00B | -372.26B | -248.32B | -257.78B | -264.21B | -208.48B | -208.68B | -241.43B | -228.29B |
Investments In Property Plant And Equipment | -71.94B | -71.23B | -72.86B | -61.41B | -61.17B | -77.67B | -44.52B | -36.42B | -25.26B | -19.16B |
Acquisitions Net | 0 | 1.04B | 6.89B | 4.34B | 8.16B | 5.88B | -10.85B | -5.94B | -6.11B | -1.65B |
Cash generated by investing activities | -37.29B | -145.99B | -118.92B | -98.31B | -81.74B | -74.06B | -36.71B | -10.10B | -45.26B | -14.35B |
Financing activities | ||||||||||
Common Stock Issued | 217M | 241M | 322M | 440M | 735M | 996M | 922M | 506M | 1.40B | 1.22B |
Payments for dividends | -131.59B | -138.22B | -98.64B | -91.44B | -56.37B | -35.01B | -30.05B | -31.67B | -28.37B | -24.52B |
Repurchases of common stock | 0 | -5M | -8M | -30M | -25M | -19M | -20M | -7M | 0 | -19M |
Repayments of term debt | 0 | 0 | 0 | -8.46B | 0 | -796M | 0 | -1.11B | 0 | -968M |
Cash used in financing activities | -139.33B | -145.64B | -107.40B | -99.49B | -66.87B | -35.01B | -29.56B | -33.41B | -28.46B | -24.38B |
Net Change In Cash | 236.50B | -45.58B | 55.42B | 8.39B | 57.08B | 7.78B | 43.70B | -6.33B | -12.33B | -1.03B |
Cash at end of period | 458.67B | 222.16B | 267.75B | 212.33B | 203.94B | 146.86B | 139.07B | 95.36B | 101.70B | 114.03B |